Clinical Trials
10 trialsNCT04425070 2026-01-05
TOUCH
Antengene Corporation
Phase 1/2 Terminated
NCT06520163 2025-12-04
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
The Affiliated People's Hospital of Ningbo University
Phase 3 Recruiting
NCT06594354 2025-06-19
Oral Cryotherapy Applied to Patients Undergoing Chemotherapy
Karadeniz Technical University
Phase NA Completed
NCT04822597 2023-08-03
Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer
University of Wisconsin, Madison
Phase 3 Completed
NCT01453205 2018-03-12
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
MedImmune LLC
Phase 2 Completed
NCT01529658 2016-10-27
Renal Hypothermia During Partial Nephrectomy
Ottawa Hospital Research Institute
Phase NA Unknown
NCT02856997 2016-08-05
Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT00020722 2016-02-17
Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer
Barbara Ann Karmanos Cancer Institute
Phase 2 Terminated
NCT01424839 2015-06-04
SIOPCNSGCTII
University Hospital Muenster
Phase 4 Unknown
NCT00823719 2013-03-12
Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)
GlaxoSmithKline
Phase 2 Completed